Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
We have generated a human iPSC line IISHDOi003-A from fibroblasts of a patient with a dominant optic atrophy 'plus' phenotype, harbouring a heterozygous mutation, c.1635C>A; p.Ser545Arg, in the OPA1 gene. Reprogramming factors Oct3/4, Sox2, Klf4, and c-Myc were delivered using Sendai virus.
Pubmed ID: 29034899
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This polyclonal secondary targets IgG (H+L)
View all literature mentionsThis unknown targets Mouse IgG, Fc? Subclass 3 Specific
View all literature mentionsThis monoclonal targets TRA-1-81 clone TRA-1-81
View all literature mentionsThis monoclonal targets HSP90B1
View all literature mentionsThis unknown targets Mouse IgM,
View all literature mentionsThis monoclonal targets Stage-Specific Embryonic Antigen-4
View all literature mentionsThis monoclonal targets Human SSEA3
View all literature mentionsThis monoclonal targets Actin, α-Smooth Muscle
View all literature mentionsThis monoclonal targets Oct-3/4
View all literature mentionsThis monoclonal targets Anti-Goat IgG (H+L)
View all literature mentionsThis unknown targets Rabbit IgG (H+L)
View all literature mentionsThis unknown targets Rat IgM,
View all literature mentionsThis monoclonal targets β-Tubulin III
View all literature mentionsThis unknown targets SOX2
View all literature mentionsThis unknown targets Mouse IgG, Fc? Subclass 2b Specific
View all literature mentionsThis monoclonal targets Human AFP
View all literature mentions